牛皮疾病的挑战和机遇:对未来的综合观点
Lyn Chinchay1, Kaiyang Song2, Jeffrey Stark3
1L. Chinchay, MD, MS, Department of Rheumatology, Carita Feliz Clinic, Piura, Peru.
The Journal of rheumatology
|August 5, 2025
概括
牛皮病 (PsD),包括牛皮 (PsO) 和牛皮关节炎 (PsA),影响全球数百万人. 进步提供了更好的护理,但对病原和并发症的研究对于个性化治疗和改善生活质量至关重要.
科学领域:
- 风湿病学和皮肤病学
- 免疫学和遗传学
- 计算生物学和健康信息学
背景情况:
- 牛皮病 (PsD),包括皮肤牛皮 (PsO) 和牛皮关节炎 (PsA),影响全球人口的2%.
- 皮肤病导致伴随性疾病,对生活质量 (QOL) 和身体功能产生负面影响.
- 目前的管理层面临着在实现适当的治疗反应和个性化护理方面面临的挑战.
研究的目的:
- 总结最近在牛皮病管理方面的进展和持续挑战.
- 为突出牛皮病研究和治疗的未来方向.
- 讨论不同学科和技术的整合,以改善患者的治疗结果.
主要方法:
- 审查最近在PsD的诊断和治疗策略的进展.
- 讨论在实现适当的治疗反应和精密护理方面的挑战.
- 探索未来的研究途径,包括人工智能,分子解剖和跨学科方法.
主要成果:
- 早期诊断和创新的免疫向疗法改善了PsD护理.
- 目前尚无PsD的治疗方法,因此需要对病原和并发症进行持续的研究.
- 临床学科和先进技术的整合可能会导致个性化治疗.
结论:
- 在PsD管理的未来进展取决于了解疾病的病原和伴随性疾病.
- 利用人工智能和分子解剖可以确定新的治疗策略.
- 个性化治疗方法和对PsD并发症的更好理解将提高患者的QOL和结果.
相关概念视频
EPS and iPS Cells in Disease Research
2.9K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.9K
Chronic Pancreatitis II: Collaborative Care
128
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
128
Peripheral Artery Disease III: Interprofessional Care
29
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
29
Chronic Obstructive Pulmonary Disease-V: Management
2.7K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.7K
Atherosclerosis III: Management
35
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
35
Peripheral Artery Disease I: Introduction
33
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
33


